Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Antitrust Laws”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 919 records · Page 51Linked to original sources

Department of Justice challenging big insurers' "Most Favored Nation" clauses.

The DOJ's latest actions suggest that MFNs in managed care contracts should be evaluated on a case-by-case basis, focusing on the actual or potential impact that the MFNs have on price competition among providers and payors in the relevant marketplace. For health care providers desiring to avoid MFNs, however, the DOJ's heightened activity in this area might furnish an appropriate reason to resist such clauses. To date, the DOJ's focus has been on the market power of payors with MFN status. However, the DOJ's reasoning applies equally to providers that wield buying power in contracting with others. Although the DOJ has yet to take up this latter issue, MFNs imposed by increasingly powerful provider organizations can expect to receive similar scrutiny from the DOJ, especially as their market influence grows.

Antitrust Laws↗

How hospitals can avoid antitrust exposures.

Healthcare institutions' growing diversity of business activities increasingly exposes them to antitrust liability. Greater exposure threatens assets not only of institutions, but of their officers and directors as well. Chief financial officers should be aware of emerging exposures and consider transferring risks through the use of directors' and officers' and entity liability insurance.

Antitrust Laws↗